Can cutting-edge tech help battle neurodegenerative diseases?

GSK

Partner Content

This content was paid for by GSK and produced in partnership with the Financial Times Commercial department

> Can cutting-edge tech help battle neurodegenerative diseases?

Watch top experts discuss how new science-technology partnerships and patient input are taking on devastating illnesses

3 minutes

More from GSK

4 min read

Can you hear me? HIV community tells industry the struggle is not over

How community activism translates into innovative medicines

5 min read

Breakthroughs in vaccine innovation are helping to protect more lives

The latest in vaccine science and technology offers the potential of a healthier lifestyle for an ageing population

5 min read

Scientists and technology are putting data to work for patients

A pioneering partnership is bringing together patients, scientists and technology to outsmart neurological diseases

Connect with us

Stay up-to-date with the latest perspectives from GSK